Article
Abstract 5406: ErbB inhibitory protein [EBIP], a modified ectodomain of EGFR, synergizes with dasatinib to inhibit growth of breast cancer cells
Cancer Research
(2010)
Disciplines
Publication Date
April 15, 2010
DOI
10.1158/1538-7445.AM10-5406
Citation Information
Jyoti Nautiyal, Yingjie Yu, Amro Aboukameel, Shailender Singh Kanwar, et al.. "Abstract 5406: ErbB inhibitory protein [EBIP], a modified ectodomain of EGFR, synergizes with dasatinib to inhibit growth of breast cancer cells" Cancer Research Vol. 70 (2010) p. 5406 - 5406 Available at: http://works.bepress.com/jayanta-das/26/